Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.62
+0.04000.15%
Post-market: 26.620.00000.00%19:59 EST
Volume:30.89M
Turnover:821.48M
Market Cap:151.35B
PE:19.57
High:26.78
Open:26.77
Low:26.35
Close:26.58
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.82
T/O Rate:0.54%
Dividend:1.72
Dividend Rate:6.46%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.75
PE(LYR):19.51

Loading ...

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 28

Why Is Pfizer Stock Rising Tuesday?

Benzinga
·
Jan 28

Pfizer Is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
Jan 28

Moderately bullish activity in Pfizer with shares up 2.14%

TIPRANKS
·
Jan 27

Citi Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Jan 27

Cantor Fitzgerald Adjusts Price Target on Pfizer to $27 From $24, Maintains Neutral Rating

MT Newswires Live
·
Jan 27

Earning Preview: Pfizer’s revenue is expected to decrease by 2.32%, and institutional views are cautious

Earnings Agent
·
Jan 27

Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch

TIPRANKS
·
Jan 27

Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research

Benzinga_recent_news
·
Jan 24

Mixed options sentiment in Pfizer with shareslittle changed

TIPRANKS
·
Jan 24

Pfizer Takes Aim at Keytruda in New Phase 3 Lung Cancer Study: What Investors Should Know

TIPRANKS
·
Jan 24

Pfizer Advances New COPD Candidate Into Phase 2/3, Adding Depth to Its Post-COVID Pipeline

TIPRANKS
·
Jan 24

Option Movers | Pfizer Sees 96% Call Options; Meta's $650 Call Soars 2990%

Option Movers
·
Jan 23

Pfizer Advances PF-07248144 With New Drug–Interaction Study, Signaling Quiet Pipeline Progress

TIPRANKS
·
Jan 23

Pfizer's (PFE.US) Class 1 Innovative Drug Submits New Indication Application in China

Stock News
·
Jan 22

Mixed options sentiment in Pfizer with shares up 1.51%

TIPRANKS
·
Jan 22

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22

Pfizer CEO Takes Aim at Kennedy Over Vaccines -- WSJ

Dow Jones
·
Jan 21

DAVOS: Pfizer CEO Says AI Creating 'Scientific Renaissance -- Market Talk

Dow Jones
·
Jan 21

DAVOS: Pfizer CEO Says China Is Close to U.S. in Science -- Market Talk

Dow Jones
·
Jan 21